Molecular imaging using PET for breast cancer

被引：17

作者：

Kurihara, Hiroaki ^{[1
]}

Shimizu, Chikako ^{[2
]}

Miyakita, Yasuji ^{[3
]}

Yoshida, Masayuki ^{[4
]}

Hamada, Akinobu ^{[5
]}

Kanayama, Yousuke ^{[6
]}

Yonemori, Kan ^{[2
]}

Hashimoto, Jun ^{[2
]}

Tani, Hitomi ^{[1
]}

Kodaira, Makoto ^{[2
]}

Yunokawa, Mayu ^{[2
]}

Yamamoto, Harukaze ^{[2
]}

Watanabe, Yasuyoshi ^{[6
]}

Fujiwara, Yasuhiro ^{[2
]}

Tamura, Kenji ^{[2
]}

机构：

[1] Natl Canc Ctr, Dept Diagnost Radiol, Chuo Ku, Tokyo 1040045, Japan

[2] Natl Canc Ctr, Dept Breast & Med Oncol, Tokyo 1040045, Japan

[3] Natl Canc Ctr, Dept Neurosurg, Tokyo 1040045, Japan

[4] Natl Canc Ctr, Dept Pathol & Clin Labs, Tokyo 1040045, Japan

[5] Natl Canc Ctr, Res Inst, Dept Clin Pharmacol Grp, Translat Res Support Core, Tokyo 104, Japan

[6] RIKEN, Ctr Mol Imaging Sci, Kobe, Hyogo, Japan

来源：

BREAST CANCER | 2016年 / 23卷 / 01期

关键词：

Breast cancer; PET; Molecular imaging; Molecular target therapy; HER2; POSITRON-EMISSION-TOMOGRAPHY; ESTROGEN-RECEPTOR; FDG-PET; WHOLE-BODY; NEOADJUVANT CHEMOTHERAPY; ADJUVANT CHEMOTHERAPY; F-18-FDG PET; TRASTUZUMAB; TUMOR; EXPRESSION;

D O I：

10.1007/s12282-015-0613-z

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Molecular imaging can visualize the biological processes at the molecular and cellular levels in vivo using certain tracers for specific molecular targets. Molecular imaging of breast cancer can be performed with various imaging modalities, however, positron emission tomography (PET) is a sensitive and non-invasive molecular imaging technology and this review will focus on PET molecular imaging of breast cancer, such as FDG-PET, FLT-PET, hormone receptor PET, and anti-HER2 PET.

引用

页码：24 / 32

页数：9

共 80 条

[71] Pilot clinical trial of 18F-fluorodeoxyglucose positron-emission mammography in the surgical management of breast cancer [J].

Tafra, L ;

Cheng, Z ;

Uddo, J ;

Lobrano, MB ;

Stein, W ;

Berg, WA ;

Levine, E ;

Weinberg, IN ;

Narayanan, D ;

Ross, E ;

Beylin, D ;

Yarnall, S ;

Keen, R ;

Sawyer, K ;

Van Geffen, J ;

Freimanis, RL ;

Staab, E ;

Adler, LP ;

Lovelace, J ;

Shen, P ;

Stewart, J ;

Dolinsky, S .

AMERICAN JOURNAL OF SURGERY, 2005, 190 (04) :628-632

[72] 64Cu-DOTA-Trastuzumab PET Imaging in Patients with HER2-Positive Breast Cancer [J].

Tamura, Kenji ;

Kurihara, Hiroaki ;

Yonemori, Kan ;

Tsuda, Hitoshi ;

Suzuki, Junko ;

Kono, Yuzuru ;

Honda, Natsuki ;

Kodaira, Makoto ;

Yamamoto, Harukaze ;

Yunokawa, Mayu ;

Shimizu, Chikako ;

Hasegawa, Koki ;

Kanayama, Yousuke ;

Nozaki, Satoshi ;

Kinoshita, Takayuki ;

Wada, Yasuhiro ;

Tazawa, Shusaku ;

Takahashi, Kazuhiro ;

Watanabe, Yasuyoshi ;

Fujiwara, Yasuhiro .

JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (11) :1869-1875

[73] Safety of treatment of metastatic breast cancer with trastuzumab beyond disease progression [J].

Tripathy, D ;

Slamon, DJ ;

Cobleigh, M ;

Arnold, A ;

Saleh, M ;

Mortimer, JE ;

Murphy, M ;

Stewart, SJ .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (06) :1063-1070

[74] Imaging in breast cancer - Diffuse optics in breast cancer: detecting tumors in pre-menopausal women and monitoring neoadjuvant chemotherapy [J].

Tromberg, BJ ;

Cerussi, A ;

Shah, N ;

Compton, M ;

Durkin, A ;

Hsiang, D ;

Butler, J ;

Mehta, R .

BREAST CANCER RESEARCH, 2005, 7 (06) :279-285

[75] Assessing the future of diffuse optical imaging technologies for breast cancer management [J].

Tromberg, Bruce J. ;

Pogue, Brian W. ;

Paulsen, Keith D. ;

Yodh, Arjun G. ;

Boas, David A. ;

Cerussi, Albert E. .

MEDICAL PHYSICS, 2008, 35 (06) :2443-2451

[76] PRECLINICAL EVALUATION OF A POSITRON EMITTING PROGESTIN ([F-18]FLUORO-16-ALPHA-METHYL-19-NORPROGESTERONE) FOR IMAGING PROGESTERONE-RECEPTOR POSITIVE TUMORS WITH POSITRON EMISSION TOMOGRAPHY [J].

VERHAGEN, A ;

LUURTSEMA, G ;

PESSER, JW ;

DEGROOT, TJ ;

WOUDA, S ;

OOSTERHUIS, JW ;

VAALBURG, W .

CANCER LETTERS, 1991, 59 (02) :125-132

[77] A new PET tracer specific for vascular endothelial growth factor receptor 2 [J].

Wang, Hui ;

Cai, Weibo ;

Chen, Kai ;

Li, Zi-Bo ;

Kashefi, Amir ;

He, Lina ;

Chen, Xiaoyuan .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (12) :2001-2010

[78] Assessment of 11C-labeled-4-N-(3-bromoanilino)-6,7-dimethoxyquinazoline as a positron emission tomography agent to monitor epidermal growth factor receptor expression [J].

Wang, Hui ;

Yu, Jinming ;

Yang, Guoren ;

Song, Xianrang ;

Sun, Xiaorong ;

Zhao, Shuqiang ;

Mu, Dianbin .

CANCER SCIENCE, 2007, 98 (09) :1413-1416

[79] Stability of HER2-positive status in breast carcinoma: a comparison between primary and paired metastatic tumors with regard to the possible impact of intervening trastuzumab treatment [J].

Xiao, C. ;

Gong, Y. ;

Han, E. Y. ;

Gonzalez-Angulo, A. M. ;

Sneige, N. .

ANNALS OF ONCOLOGY, 2011, 22 (07) :1547-1553

[80] Synthesis of an estrogen receptor β-selective radioligand:: 5-[18F]Fluoro-(2R*,3S*)-2,3-bis(4-hydroxyphenyl)pentanenitrile and comparison of in vivo distribution with 16α-[18F]Fluoro-17β-estradiol [J].

Yoo, J ;

Dence, CS ;

Sharp, TL ;

Katzenellenbogen, JA ;

Welch, MJ .

JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (20) :6366-6378

← 1 2 3 4 5 6 7 8 →